ATCOR develops innovative medical devices and digital solutions that help identify and reduce the risk of hypertension, cardiovascular disease (CVD), and other related vascular disorders. Early detection with SphygmoCor® technology allows clinicians to detect target organ damage and manage cardiova...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
SYDNEY, NSW 2000, AU
LOW
spending power
